Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue -, Pages 346-357Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2012.07.039
Keywords
4-Arylidene curcumin analogues; Cytotoxicity; NF-kappa B inhibition; Akt inhibition; Docking
Categories
Funding
- National High-tech RD 863 Program [2008AA02Z304]
- National Program on Key Basic Research Project 973 Program [2011CB935800]
- National Nature Science Foundation of China [30973619, 81172931]
- Fundamental Research Funds for the Central Universities of China [09ykpy66]
Ask authors/readers for more resources
A series of new 4-arylidene curcumin analogues (4-arylidene-1,7-bisarylhepta-1,6-diene-3,5-diones) were synthesized and found to be potent antiproliferative agents against a panel of cancer cell lines at submicromolar to low micromolar concentrations by SRB assay. Their inhibitory abilities against NF-kappa B was evaluated by High Content Analysis (HCA) based immunofluorescence assay; and the Akt signalling inhibition was determined by fluorescence polarization assay and western blot respectively. The Structure Activity Relationship was discussed. Our results revealed that 4-arylidene curcumin analogues may work in a multi-targets manner in cancer cell. (C) 2012 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available